Add to ORKGThe recent decline in smoking prevalence in most advanced to-bacco markets has been attributed to a synergism of tobacc
Tobacco use is the leading cause of preventable disease and death in the United States.1 The prevale...
BackgroundIn response to a changing regulatory and consumer landscape, tobacco companies developed n...
tobaccocontrol-2013-051392 Objective Regulations that reduce nicotine and eliminate menthol in cigar...
Smoking remains the leading cause of mortality and morbidity in the United States, with almost 450,0...
Developments in tobacco harm reduction (HR) and the proliferation of nicotine containing products (N...
Over the past two decades a wealth of research findings have pointed to nicotine as the key pharmaco...
ObjectiveTo assess the feasibility of reducing tobacco-caused disease by gradually removing nicotine...
BackgroundReducing nicotine content in cigarettes and other combustible products to levels that are ...
What does research on nicotine and tobacco use have to offer that is relevant and possibly useful to...
There are no funding or competing interests regarding this manuscript Tobacco use started several ce...
Objectives: To determine whether nicotine yields in the smoke of cigarettes would show an overall in...
INTRODUCTION: Recent increases in nicotine yield of cigarettes sold in United States have been attri...
Tobacco use continues to be the leading global cause of leads to reduced mortality, in particular, i...
BackgroundIn response to a changing regulatory and consumer landscape, tobacco companies developed n...
Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict s...
Tobacco use is the leading cause of preventable disease and death in the United States.1 The prevale...
BackgroundIn response to a changing regulatory and consumer landscape, tobacco companies developed n...
tobaccocontrol-2013-051392 Objective Regulations that reduce nicotine and eliminate menthol in cigar...
Smoking remains the leading cause of mortality and morbidity in the United States, with almost 450,0...
Developments in tobacco harm reduction (HR) and the proliferation of nicotine containing products (N...
Over the past two decades a wealth of research findings have pointed to nicotine as the key pharmaco...
ObjectiveTo assess the feasibility of reducing tobacco-caused disease by gradually removing nicotine...
BackgroundReducing nicotine content in cigarettes and other combustible products to levels that are ...
What does research on nicotine and tobacco use have to offer that is relevant and possibly useful to...
There are no funding or competing interests regarding this manuscript Tobacco use started several ce...
Objectives: To determine whether nicotine yields in the smoke of cigarettes would show an overall in...
INTRODUCTION: Recent increases in nicotine yield of cigarettes sold in United States have been attri...
Tobacco use continues to be the leading global cause of leads to reduced mortality, in particular, i...
BackgroundIn response to a changing regulatory and consumer landscape, tobacco companies developed n...
Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict s...
Tobacco use is the leading cause of preventable disease and death in the United States.1 The prevale...
BackgroundIn response to a changing regulatory and consumer landscape, tobacco companies developed n...
tobaccocontrol-2013-051392 Objective Regulations that reduce nicotine and eliminate menthol in cigar...